CN101600418A - 用于加入饮水系统中的氟苯尼考的泡腾制剂 - Google Patents

用于加入饮水系统中的氟苯尼考的泡腾制剂 Download PDF

Info

Publication number
CN101600418A
CN101600418A CNA2007800470236A CN200780047023A CN101600418A CN 101600418 A CN101600418 A CN 101600418A CN A2007800470236 A CNA2007800470236 A CN A2007800470236A CN 200780047023 A CN200780047023 A CN 200780047023A CN 101600418 A CN101600418 A CN 101600418A
Authority
CN
China
Prior art keywords
effervescent formulation
effervescent
florfenicol
formulation
basic component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800470236A
Other languages
English (en)
Chinese (zh)
Inventor
S·汤吉亚尼
K·弗里豪夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Schering Plough Ltd Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd Switzerland filed Critical Schering Plough Ltd Switzerland
Publication of CN101600418A publication Critical patent/CN101600418A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2007800470236A 2006-12-19 2007-12-17 用于加入饮水系统中的氟苯尼考的泡腾制剂 Pending CN101600418A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87070506P 2006-12-19 2006-12-19
US60/870,705 2006-12-19

Publications (1)

Publication Number Publication Date
CN101600418A true CN101600418A (zh) 2009-12-09

Family

ID=39496160

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800470236A Pending CN101600418A (zh) 2006-12-19 2007-12-17 用于加入饮水系统中的氟苯尼考的泡腾制剂

Country Status (10)

Country Link
US (1) US20080145317A1 (enExample)
EP (1) EP2120858A2 (enExample)
JP (1) JP2010513487A (enExample)
KR (1) KR20090090387A (enExample)
CN (1) CN101600418A (enExample)
BR (1) BRPI0720492A2 (enExample)
CA (1) CA2672863A1 (enExample)
MX (1) MX2009006714A (enExample)
RU (1) RU2009127496A (enExample)
WO (1) WO2008085310A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103550755A (zh) * 2013-11-04 2014-02-05 河南牧翔动物药业有限公司 一种氟苯尼考硫酸粘菌素可溶性粉及其制备方法
CN114917193A (zh) * 2022-05-07 2022-08-19 广东温氏大华农生物科技有限公司 一种适应复杂水质的盐酸金霉素可溶性粉及其制备方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2004001293A1 (es) 2003-05-29 2005-05-06 Schering Plough Ltd Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u
EP2102154A1 (en) * 2006-12-13 2009-09-23 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
RU2010123282A (ru) * 2007-11-09 2011-12-20 Интэрвэт Интэрнэшнл Б.Ф. (NL) Твердая лекарственная форма с быстрым высвобождением активного вещества, ее получение и применение
FR2925335B1 (fr) * 2007-12-21 2010-03-19 Ceva Sante Animale Compositions orales liquides de florfenicol diluables dans l'eau de boisson
JP2011529895A (ja) * 2008-07-30 2011-12-15 インターベツト・インターナシヨナル・ベー・ベー フロルフェニコール中間体として有用なオキサゾリン保護アミノジオール化合物を調製する方法
BRPI1002023A2 (pt) * 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
CN101966200A (zh) * 2010-07-26 2011-02-09 天津生机集团股份有限公司 用于治疗禽消化道细菌感染的组合物及其制备方法
CN101972237A (zh) * 2010-08-14 2011-02-16 格特生物制药（天津）有限公司 一种畜禽用泡腾片的制备方法
EP2491920A1 (en) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Effervescent tablet, sachet and dry syrup of gemifloxacin
WO2014174405A1 (en) * 2013-04-22 2014-10-30 Webb Johannes Arnoldus Vosloo Pharmaceutical preparation
EP2995297A1 (fr) * 2014-09-09 2016-03-16 Ceva Sante Animale Compositions parentérales et leurs utilisations
CN105640889A (zh) * 2014-11-11 2016-06-08 天津嘉创生物科技有限公司 氟苯尼考可溶性粉及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions
US4655782A (en) * 1985-12-06 1987-04-07 Lever Brothers Company Bleach composition of detergent base powder and agglomerated manganese-alluminosilicate catalyst having phosphate salt distributed therebetween
DE69102900T3 (de) * 1990-02-14 1998-04-09 Otsuka Pharma Co Ltd Brausemischung, deren Herstellung sowie Verwendung.
GB9009473D0 (en) * 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
US6121215A (en) * 1999-08-27 2000-09-19 Phyzz, Inc. Foaming effervescent bath product
US6503927B1 (en) * 1999-10-28 2003-01-07 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
CL2004001293A1 (es) * 2003-05-29 2005-05-06 Schering Plough Ltd Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103550755A (zh) * 2013-11-04 2014-02-05 河南牧翔动物药业有限公司 一种氟苯尼考硫酸粘菌素可溶性粉及其制备方法
CN103550755B (zh) * 2013-11-04 2015-05-20 河南牧翔动物药业有限公司 一种氟苯尼考硫酸粘菌素可溶性粉及其制备方法
CN114917193A (zh) * 2022-05-07 2022-08-19 广东温氏大华农生物科技有限公司 一种适应复杂水质的盐酸金霉素可溶性粉及其制备方法
CN114917193B (zh) * 2022-05-07 2023-05-30 广东温氏大华农生物科技有限公司 一种适应复杂水质的盐酸金霉素可溶性粉及其制备方法

Also Published As

Publication number Publication date
JP2010513487A (ja) 2010-04-30
RU2009127496A (ru) 2011-01-27
KR20090090387A (ko) 2009-08-25
MX2009006714A (es) 2009-08-31
US20080145317A1 (en) 2008-06-19
WO2008085310A3 (en) 2008-08-21
EP2120858A2 (en) 2009-11-25
BRPI0720492A2 (pt) 2014-02-04
WO2008085310A2 (en) 2008-07-17
CA2672863A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
JP5193308B2 (ja) 迅速な放出の液体調合物、調製物およびその使用
CN101600418A (zh) 用于加入饮水系统中的氟苯尼考的泡腾制剂
US20090062397A1 (en) Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins
UA72541C2 (en) A pharmaceutical composition containing benzamide derivative
HU206265B (en) Process for producing pharmaceutical compositions comprising morphine
US10933040B2 (en) Production process for NSAID-containing lozenges, their compositions, their medicinal use
EP0976395B1 (en) Tablet for extended release of a drug in the stomach
CN105213402A (zh) 一种畜禽复方恩诺沙星美洛昔康可溶性粉
EP2117534B1 (en) A pharmaceutical composition with atorvastatin active ingredient
GB2573784A (en) A stable aqueous hydroxycarbamide solution
AU2024229531A1 (en) Liquid formulation comprising trilostane
JPS61293912A (ja) 配合剤及びその製造法
BG66613B1 (bg) Прахообразен фармацевтичен състав, съдържащ метамизол

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20091209